IP Library Granted Patent US 10,398,824
Granted Patent B2
US 10,398,824 · App. 14/856,447 · Granted Sep 3, 2019

Dialysis implant and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,398,824
App. No.
14/856,447
Granted
Sep 3, 2019
Kind
B2
Abstract

A device and methods for treating renal failure are disclosed. One embodiment of the device is an implantable peritoneal dialysis device. When in use, the device can have a semi-permeable reservoir implanted in the peritoneal cavity. The reservoir can receive blood waste and drain through one or more conduits, via a pump, to the biological bladder. Solids and/or a solution benefiting dialysis can be pumped to the reservoir and/or implanted in the peritoneal cavity.

Claims (21)

1. A fluid management system comprising:

an infusate comprising an osmotic agent for infusion into a peritoneal cavity;

a reservoir conduit adapted for introducing the infusate into the peritoneal cavity;

an implantable pump having an internal battery that is inductively chargeable, the implantable pump adapted for fluidic communication with the peritoneal cavity and a bladder;

a drainage conduit adapted for coupling between the peritoneal cavity and the implantable pump; and

an exit conduit adapted for coupling between the bladder and the implantable pump,

wherein the implantable pump is configured to pump a peritoneal fluid mixture from the peritoneal cavity through the drainage conduit into the bladder through the exit conduit, and

wherein the peritoneal fluid mixture comprises the infusate comprising the osmotic agent.

2. The system of claim 1 , further comprising an implantable controller associated with the implantable pump.

3. The system of claim 2 , wherein the implantable controller is configured to monitor a physiologic parameter, the implantable controller programmed to cause the implantable pump to pump the peritoneal fluid mixture from the peritoneal cavity to the bladder responsive to a value of the monitored physiologic parameter.

4. The system of claim 3 , wherein the monitored physiological parameter comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the peritoneal cavity or the bladder or both.

5. The system of claim 2 , wherein the implantable controller is configured to monitor a difference in pressure between the peritoneal cavity and the bladder.

6. The system of claim 1 , further comprising a reservoir adapted for coupling to the implantable pump via the reservoir conduit,

wherein the implantable pump is configured to pump the infusate comprising the osmotic agent from the reservoir through the reservoir conduit into the peritoneal cavity through the drainage conduit to form the peritoneal fluid mixture in the peritoneal cavity.

7. The system of claim 6 , further comprising an implantable controller associated with the implantable pump, the implantable controller configured to monitor a physiologic parameter, the implantable controller programmed to cause the implantable pump to pump the infusate from the reservoir to the peritoneal cavity responsive to a value of the monitored physiologic parameter.

8. The system of claim 7 , wherein the monitored physiological parameter comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the peritoneal cavity or the bladder or both.

9. The system of claim 6 , wherein the implantable pump is configured to pump the infusate comprising the osmotic agent from the reservoir through the reservoir conduit into the peritoneal cavity through the drainage conduit as a function of time.

10. The system of claim 6 , wherein the reservoir is adapted for implantation.

11. The system of claim 1 , wherein the implantable pump is configured to pump the peritoneal fluid mixture from the peritoneal cavity through the drainage conduit into the bladder through the exit conduit as a function of time.

12. The system of claim 1 , further comprising an inductive recharging circuit for recharging the internal battery.

13. The system of claim 1 , wherein the drainage conduit comprises a semi-permeable conduit.

Assignments (10)
SECURITY INTEREST Recorded Feb 27, 2025
From: DSRCO BV
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070356/0934 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2025
From: SEQUANA MEDICAL NV
To: DSRCO BV
Reel/Frame 070308/0171 →
SECURITY INTEREST Recorded Sep 25, 2024
From: SEQUANA MEDICAL NV
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 069049/0129 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2020
From: BOOTSTRAP EUROPE S.C.SP.
To: SEQUANA MEDICAL NV
Reel/Frame 053375/0176 →
CHANGE OF NAME Recorded Jun 9, 2019
From: SEQUANA MEDICAL AG
To: SEQUANA MEDICAL NV
Reel/Frame 049414/0245 →
SECURITY INTEREST Recorded Sep 28, 2016
From: SEQUANA MEDICAL AG
To: BOOTSTRAP EUROPE S.C.SP.
Reel/Frame 039884/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2015
From: BURNETT, DANIEL R; HALL, GREGORY W
To: THERANOVA, LLC
Reel/Frame 036626/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2015
From: THERANOVA, LLC
To: NOVASHUNT, INC.
Reel/Frame 036627/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2015
From: NOVASHUNT, INC.
To: NOVASHUNT AG
Reel/Frame 036627/0073 →
CHANGE OF NAME Recorded Sep 22, 2015
From: NOVASHUNT AG
To: SEQUANA MEDICAL AG
Reel/Frame 036664/0201 →
Cited By (1)
US 12,623,011